ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 23 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,235,000 | -35.3% | 137,728 | 0.0% | 0.20% | -45.5% |
| Q4 2021 | $1,908,000 | +29.8% | 137,728 | 0.0% | 0.37% | +37.5% |
| Q3 2021 | $1,470,000 | +18.5% | 137,728 | 0.0% | 0.27% | +25.3% |
| Q2 2021 | $1,240,000 | -15.1% | 137,728 | 0.0% | 0.22% | -24.4% |
| Q1 2021 | $1,460,000 | -15.9% | 137,728 | 0.0% | 0.29% | -27.2% |
| Q4 2020 | $1,735,000 | +43.3% | 137,728 | 0.0% | 0.39% | +14.2% |
| Q3 2020 | $1,211,000 | -9.4% | 137,728 | 0.0% | 0.34% | -6.5% |
| Q2 2020 | $1,337,000 | +236.8% | 137,728 | 0.0% | 0.37% | +177.4% |
| Q1 2020 | $397,000 | -25.0% | 137,728 | 0.0% | 0.13% | -11.3% |
| Q4 2019 | $529,000 | -2.9% | 137,728 | 0.0% | 0.15% | -27.5% |
| Q3 2019 | $545,000 | -6.0% | 137,728 | 0.0% | 0.21% | -11.9% |
| Q2 2019 | $580,000 | -38.6% | 137,728 | 0.0% | 0.24% | -9.6% |
| Q1 2019 | $945,000 | +57.8% | 137,728 | -15.4% | 0.26% | +71.1% |
| Q4 2018 | $599,000 | -41.8% | 162,728 | 0.0% | 0.15% | +47.6% |
| Q3 2018 | $1,030,000 | -16.4% | 162,728 | 0.0% | 0.10% | -58.5% |
| Q2 2018 | $1,232,000 | -5.4% | 162,728 | 0.0% | 0.25% | +48.5% |
| Q1 2018 | $1,302,000 | -28.6% | 162,728 | 0.0% | 0.17% | -41.4% |
| Q4 2017 | $1,823,000 | -3.4% | 162,728 | 0.0% | 0.28% | -16.7% |
| Q3 2017 | $1,888,000 | – | 162,728 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $32,400,000 | 2.50% |
| Omega Fund Management, LLC | 1,284,900 | $16,190,000 | 2.43% |
| Avidity Partners Management LP | 1,248,000 | $15,725,000 | 0.51% |
| Samsara BioCapital, LLC | 399,190 | $5,030,000 | 0.51% |
| EcoR1 Capital, LLC | 741,290 | $9,340,000 | 0.50% |
| DAFNA Capital Management LLC | 113,202 | $1,426,000 | 0.42% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $1,735,000 | 0.39% |
| Orbimed Advisors | 3,070,955 | $38,694,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 198,260 | $2,498,000 | 0.22% |
| Artal Group S.A. | 593,030 | $7,472,000 | 0.16% |